Bioorganic and Medicinal Chemistry Letters p. 1557 - 1560 (2001)
Update date:2022-08-03
Topics:
Curtin, Michael L.
Florjancic, Alan S.
Heyman
Michaelides, Michael R.
Garland, Robert B.
Holms, James H.
Steinman, Douglas H.
Dellaria, Joseph F.
Gong, Jane
Wada, Carol K.
Guo, Yan
Elmore, Ildiko B.
Tapang, Paul
Albert, Daniel H.
Magoc, Terrance J.
Marcotte, Patrick A.
Bouska, Jennifer J.
Goodfellow, Carole L.
Bauch, Joy L.
Marsh, Kennan C.
Morgan, Douglas W.
Davidsen, Steven K.
Modification of the biphenyl portion of MMP inhibitor 2a gave analogue 2i which is greater than 1000-fold selective against MMP-2 versus MMP-1. The stereospecific synthesis of both enantiomers of 2i was achieved beginning with (S)- or (R)-benzyl glycidyl ether. The (S)-enantiomer, 11 (ABT-770), is orally bioavailable and efficacious in an in vivo model of tumor growth. Elsevier Science Ltd. All rights reserved.
View MoreContact:+91 - 22 - 26355700
Address:17, Lotus Business Park, Andheri West
Contact:+86-27-85733560
Address:NO.308,QINGNIAN RD.,WUHAN,CHINA
Contact:
Address:ROOM 1715, No#345 Jin Xiang Road, Pudong District
Beijing Mesochem Technology Co.,LTD
website:http://www.mesochem.com
Contact:0086-10-57862036
Address:2301, Floor 23, Building 9 Lippo Plaza, Yard 8 Ronghua Middle Road, ETDZ, Beijing, China
Contact:+86-021-6989-5597
Address:No.80 Yichuan Rd., Putuo District,Shanghai,P.R.China
Doi:10.1021/ja00022a065
(1991)Doi:10.1039/c0ce00214c
(2011)Doi:10.1016/j.cclet.2011.11.025
(2012)Doi:10.1016/0040-4039(91)80593-U
(1991)Doi:10.1021/acs.orglett.9b00553
(2019)Doi:10.1039/DT9910001765
(1991)